Iceland· IS-EU/1/19/1384/001-003
Giapreza
A angiotensin ii product containing angiotensinum ii inn acetat, registered in Iceland by PAION Pharma GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Angiotensin ii is registered in 11 of 19 countries.
Countries holding a registration under ATC C01CX09 (angiotensin ii), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Angiotensin ii · ATC C01CX09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Angiotensinum II INN acetat
- Manufacturer
- PAION Pharma GmbH
- Country
- Iceland (IS)
- ATC code
- C01CX09
- ATC class
- Angiotensin II
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Angiotensin ii in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayGiaprezaPAION Pharma GmbH
- SwedenGIAPREZA 2,5 mg/ml Koncentrat till infusionsvätska, lösningPAION Pharma GmbH
- United StatesANGIOTENSIN IIGland Pharma Limited
- FranceGIAPREZA 2,5 mg/ml, solution à diluer pour perfusionPAION PHARMA (ALLEMAGNE)
- United KingdomGiapreza 2.5mg/1ml concentrate for solution for infusion vialsPAION Pharma GmbH
- SpainGIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONPaion Pharma Gmbh
- NetherlandsGiapreza 2,5 mg/ml concentraat voor oplossing voor infusiePaion Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Giapreza
- Norway · Giapreza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a4bdbe87-f9a4-41b9-8e43-82d4912b5915 GET /v1/drugs/a4bdbe87-f9a4-41b9-8e43-82d4912b5915?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "C01CX09",
"marketed": false,
"strength": "2,5 mg/ml",
"ma_number": "EU/1/19/1384/001-003",
"substance": "Angiotensinum II INN acetat",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "43700"
}See everything about angiotensin ii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.